Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says - CNBC
- Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says CNBC
- Weight-loss drug could help slow Alzheimer’s cognitive decline, trial finds The Guardian
- Ozempic-like weight loss drugs may protect against Alzheimer's NBC News
- Novo’s Diabetes Drug Shows Mixed Results in Alzheimer’s Disease Bloomberg
- Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial CNN